Oxford Nanopore Technologies plc (LON:ONT – Get Free Report) insider Kate Priestman bought 23,564 shares of the company’s stock in a transaction on Tuesday, April 30th. The shares were acquired at an average price of GBX 106 ($1.33) per share, with a total value of £24,977.84 ($31,375.25).
Oxford Nanopore Technologies Stock Performance
Shares of ONT stock opened at GBX 106.40 ($1.34) on Friday. The business’s fifty day simple moving average is GBX 120.50 and its 200-day simple moving average is GBX 161.66. The company has a market cap of £915.00 million, a PE ratio of -709.33 and a beta of 0.59. The company has a current ratio of 5.01, a quick ratio of 6.01 and a debt-to-equity ratio of 6.47. Oxford Nanopore Technologies plc has a 12-month low of GBX 91.24 ($1.15) and a 12-month high of GBX 279 ($3.50).
Analyst Upgrades and Downgrades
Several analysts have recently weighed in on the stock. Citigroup reaffirmed a “buy” rating and set a GBX 210 ($2.64) price target on shares of Oxford Nanopore Technologies in a research note on Friday, April 12th. Berenberg Bank reaffirmed a “buy” rating and set a GBX 350 ($4.40) price target on shares of Oxford Nanopore Technologies in a research note on Wednesday, April 17th. Five research analysts have rated the stock with a buy rating, According to MarketBeat, the company has a consensus rating of “Buy” and a consensus target price of GBX 303.75 ($3.82).
Check Out Our Latest Analysis on ONT
About Oxford Nanopore Technologies
Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a nanopore based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) in the Americas, Europe, the Middle East, Africa, India, and the Asia Pacific.
Featured Articles
Receive News & Ratings for Oxford Nanopore Technologies Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Oxford Nanopore Technologies and related companies with MarketBeat.com’s FREE daily email newsletter.